Patient Perspectives on Health-Related Quality of Life in Diffuse Large B-Cell Lymphoma Treated with Car T-Cell Therapy: A Qualitative Study
出版年份 2021 全文链接
标题
Patient Perspectives on Health-Related Quality of Life in Diffuse Large B-Cell Lymphoma Treated with Car T-Cell Therapy: A Qualitative Study
作者
关键词
-
出版物
Oncology and Therapy
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-11-15
DOI
10.1007/s40487-021-00174-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Patient Experience of Chimeric Antigen Receptor (CAR)-T Cell Therapy Vs. Stem Cell Transplant: Longitudinal Patient Reported Adverse Events, Cognition and Quality of Life
- (2020) Surbhi Sidana et al. BLOOD
- Health-related quality of life (HRQOL) burden in patients with relapsed/refractory diffuse large B-cell lymphoma (RR-DLBCL) and non-Hodgkin’s lymphoma (RR-NHL).
- (2020) Vincent Lin et al. JOURNAL OF CLINICAL ONCOLOGY
- Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study
- (2020) Jeremy S Abramson et al. LANCET
- Risks and Benefits of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Cancer: A Systematic Review and Meta-Analysis
- (2019) Emma J.M. Grigor et al. TRANSFUSION MEDICINE REVIEWS
- Diffuse Large B cell Lymphoma: 2019 update on diagnosis, risk-stratification and treatment
- (2019) Yang Liu et al. AMERICAN JOURNAL OF HEMATOLOGY
- Patient-reported disease burden in chronic lymphocytic leukemia, diffuse large B-cell lymphoma, and follicular lymphoma: Results from a national patient advocacy survey.
- (2019) Mark Price et al. JOURNAL OF CLINICAL ONCOLOGY
- PROMIS® Adult Health Profiles: Efficient Short-Form Measures of Seven Health Domains
- (2019) David Cella et al. VALUE IN HEALTH
- NCCN Guidelines Insights: B-Cell Lymphomas, Version 3.2019
- (2019) Andrew D. Zelenetz et al. Journal of the National Comprehensive Cancer Network
- Patient Reported Outcomes Have Arrived: A Practical Overview for Clinicians in Using Patient Reported Outcomes in Oncology
- (2019) Rahma Warsame et al. MAYO CLINIC PROCEEDINGS
- Patient-Reported Neuropsychiatric Outcomes of Long-Term Survivors after Chimeric Antigen Receptor T Cell Therapy
- (2019) Julia Ruark et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Quality of Life of Caregivers of Hematopoietic Cell Transplant Recipients
- (2018) Kareem Jamani et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Harnessing the Power of Patient-Reported Outcomes in Oncology
- (2018) Ryan D. Nipp et al. CLINICAL CANCER RESEARCH
- Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System Recurrence
- (2018) Thomas A. Ollila et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Quality of life at diagnosis predicts overall survival in patients with aggressive lymphoma
- (2018) Carrie A. Thompson et al. HEMATOLOGICAL ONCOLOGY
- PROMIS®-29 v2.0 profile physical and mental health summary scores
- (2018) Ron D. Hays et al. QUALITY OF LIFE RESEARCH
- Patient-Reported Outcomes with Chimeric Antigen Receptor T Cell Therapy: Challenges and Opportunities
- (2018) Rajshekhar Chakraborty et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- ASBMT Consensus Grading for Cytokine Release Syndrome and Neurological Toxicity Associated with Immune Effector Cells
- (2018) Daniel W Lee et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- (2018) Stephen J. Schuster et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chimeric antigen receptor T-cell therapies for lymphoma
- (2017) Jennifer N. Brudno et al. Nature Reviews Clinical Oncology
- Chimeric antigen receptor T-cell therapy — assessment and management of toxicities
- (2017) Sattva S. Neelapu et al. Nature Reviews Clinical Oncology
- Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
- (2017) Sattva S. Neelapu et al. NEW ENGLAND JOURNAL OF MEDICINE
- International development of four EORTC disease-specific quality of life questionnaires for patients with Hodgkin lymphoma, high- and low-grade non-Hodgkin lymphoma and chronic lymphocytic leukaemia
- (2017) Lonneke van de Poll-Franse et al. QUALITY OF LIFE RESEARCH
- Integrating novel drugs to chemoimmunotherapy in diffuse large B-cell lymphoma
- (2017) Annalisa Chiappella et al. Expert Review of Hematology
- Living with a rare disorder: a systematic review of the qualitative literature
- (2017) Charlotte von der Lippe et al. Molecular Genetics & Genomic Medicine
- 2016 US lymphoid malignancy statistics by World Health Organization subtypes
- (2016) Lauren R. Teras et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Patient-Reported Outcomes Labeling for Products Approved by the Office of Hematology and Oncology Products of the US Food and Drug Administration (2010-2014)
- (2016) Ari Gnanasakthy et al. JOURNAL OF CLINICAL ONCOLOGY
- Is the EQ-5D suitable for use in oncology? An overview of the literature and recent developments
- (2016) Matthias Schwenkglenks et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2015) H. Tilly et al. ANNALS OF ONCOLOGY
- Outcomes of patients with relapsed/refractory diffuse large B-cell lymphoma with progression of lymphoma after autologous stem cell transplantation in the rituximab era
- (2013) Sarah J. Nagle et al. AMERICAN JOURNAL OF HEMATOLOGY
- Quality of life more impaired in younger than in older diffuse large B cell lymphoma survivors compared to a normative population: a study from the population-based PROFILES registry
- (2013) M. W. M. van der Poel et al. ANNALS OF HEMATOLOGY
- A preliminary study of a health related quality of life assessment of priority symptoms in advanced lymphoma: the National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy – Lymphoma Symptom Index
- (2013) Fay J. Hlubocky et al. LEUKEMIA & LYMPHOMA
- Salvage chemotherapy and autologous stem cell transplant in primary refractory diffuse large B-cell lymphoma: outcomes and prognostic factors
- (2011) David Telio et al. LEUKEMIA & LYMPHOMA
- Quality of life in patients with diffuse large B-cell lymphoma treated with dose-dense chemotherapy is only affected temporarily
- (2011) Dorte Tholstrup et al. LEUKEMIA & LYMPHOMA
- Relapsed/Refractory Diffuse Large B-Cell Lymphoma
- (2011) J. W. Friedberg Hematology-American Society of Hematology Education Program
- The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008
- (2010) David Cella et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- PRO development: rigorous qualitative research as the crucial foundation
- (2010) Kathryn Eilene Lasch et al. QUALITY OF LIFE RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search